Debra Schwab Brandt, DO

Clinician in Medicine (Medical Oncology)

Patient Care

Accepts new patients? Yes
Patient Type:
Referrals: Not Applicable

Patient Care Organizations

Medical Oncology

Cancer Center

Yale Medical Group

Board Certifications

  • Medical Oncology AB of Internal Medicine (1998)

  • Hematology (Internal Medicine) AB of Internal Medicine (1999)

Clinical Trials

Conditions Study Title
Lung A081105: Erlotinib Hydrochloride in Patients w/Stage IB-IIIA NSCLC That Has Been Removed Surgically
Lung E4512: Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been R
Lung A151216:Genetic Testing in Screening Patients w/Stage IB-IIIA NSCLC That Has Been or Will Be Removed
Lung Phase 3, MPDL3280A with Carboplatin+Paclitaxel or Carboplatin+Paclitaxel+Bevacizumab in NSCLC
Non-Hodgkin's Lymphoma Lenalidomide (CC-5013) plus R-CHOP Chemotherapy (R2-CHOP) versus placebo plus R-CHOP Chemotherapy
Bladder WO29636: IMvigor 010 Study: Anti-(PD-L1) Antibody MPDL3280A Treatment vs. Versus Observation
Breast - Female, Breast - Male Doxorubicin+Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in TNBC Patients
Lung Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent NSCLC
Bladder, Other Urinary JVDC 05 (RANGE): Ramucirumab Plus Docetaxel in Participants With Urothelial Cancer
Breast - Female, Breast - Male Neoadjuvant MEDI4736 with nab-paclitaxel followed by ddAC for stage 1-3 TNBC
Lung A randomized phase II trial of combination versus single agent chemotherapy in high-risk elderly pat
Breast - Female, Breast - Male Olaparib as Adjuvant Treatment in Patients With BRCA Mutated High Risk HER2 Negative breast cancer
Lung S1403
Lung PINNACLE: Phase 1b/2 Study of Anti-Notch Antibody Therapy with Cisplatin and Etoposide in SCLC
Other Digestive Organ, Stomach Phase 3 study of Ramucirumab in combination with Capecitabine & Cisplatin in pts with stomach cancer
Lung Safety and Efficacy of Abraxane Maintenance post Abraxane + Carboplatin in squamous cell lung cancer
Lung Biomarker-Driven Master Protocol for Squamous Cell Lung Cancer
Breast - Female Neoadj ph 2 AI plus everolimus in postmenopausal women w/ ER pos/HER2 neg, low risk score
Pancreas S1313: Phase Ib/II Study of mFOLFIRINOX +PEGPH20 vs. mFOLFIRINOX in Met. Pancreatic Adenocarcinoma
Colon S0820: Preventing Adenomas of the Colon with Eflornithine and Sulindac

Edit this profile

Contact Info

Debra Schwab Brandt, DO
Patient Care Location
Smilow Cancer Care - Torrington
200 Kennedy Drive

Torrington, CT 06790
View on map...
Mailing Address
PO Box 208028
New Haven, CT 06520-8028